Skip to main content

Advertisement

Log in

Surgery of hemophiliacs—20 years' experience

  • Original Scientific Reports
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Seventy-seven hemophilic patients of type A or type B were subjected to a total of 108 major surgical procedures mainly in the field of general surgery, orthopedic surgery, or neurosurgery. The principles for the substitution therapy in the different types of procedures and different types of hemophilic diseases are described, as well as the indications for surgery and the surgical technique. The importance of prolonged substitution therapy postoperatively to avoid late hematoma, particularly in patients with severe hemophilia undergoing major surgery, is stressed. With this type of management there has been no increased intraoperative hemorrhage, and very few cases of late hematoma formation. By combining the substitution therapy with immunosuppression, it has been possible to operate also on patients with inhibitors against factor VIII or IX. The rate of complications, particularly the incidence of hepatitis, has been low with the type of substitution given in this series of patients. It is concluded that major surgery can be carried out even in severe hemophilia without significantly increased risk. The handling of the substitution therapy, and the surgical judgment and technique, offers however, special problems, necessitating centralization of elective cases.

Résumé

Soixante-dix-sept (77) patients porteurs d'hémophylie A ou B furent soumis à un total de centhuit (108) opérations chirurgicales majeures relevant principalement de la chirurgie générale, de la chirurgie orthopédique ou de la neurochirurgie. L'article décrit les principes guidant le remplacement des facteurs anti-hémophyliques selon les différents types d'hémophylie et d'intervention ainsi que les indications opératoires et la technique chirurgicale. On y souligne l'importance de prolonger la thérapie de substitution durant la période post-opératoire pour éviter la formation d'hématome tardif, en particulier chez les cas d'hémophylie grave soumis à des interventions chirurgicales majeures. Grâce au traitement employé, on a évité les hemorragies peropératoires et quelques rares cas seulement d'hématomes post-opératoires ont été observés. En combinant le remplacement des facteurs anti-hémophyliques et l'immunosuppression, mÊme les patients porteurs d'inhibiteurs des facteurs VIII et IX ont pu Être opérés. Le taux de complication, en particulier l'incidence d'hépatite, est demeuré bas. En conclusion, l'hémophylie mÊme sévère est compatible avec la chirurgie majeure et ce, sans augmentation significative du risque opératoire. Cependant, l'application du traitement de substitution de mÊme que le jugement et la technique chirurgicale posent des problÊmes importants qui nécessitent la centralisation des cas électifs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Craddock, C.G., Jr., Fenninger, L.D., Simmons, B.: Hemophilia. Problem of surgical intervention for accompanying diseases. Review of the literature and report of a case. Ann. Surg.128:888, 1948

    Google Scholar 

  2. Pieper, G.R., Perry, S., Burroughs, J.: Surgical intervention in hemophilia. Review of the literature and report of two cases. JAMA170:33, 1959

    Google Scholar 

  3. Bidwell, E.: The purification of bovine antihaemophilic globulin. Br. J. Haematol.1:35, 1955

    Google Scholar 

  4. Biggs, R., MacFarlane, R.G. (editors): Treatment of Haemophilia and Other Coagulation Disorders. Oxford, Blackwell Scientific Publications, 1966

    Google Scholar 

  5. BlombÄck, B., BlombÄck, M.: Purification of human and bovine fibrinogen. Arkiv. Kemi.10:415, 1956

    Google Scholar 

  6. Nilsson, I.M., BlombÄck, B., BlombÄck, M., Svennerud, S.: Kvinnlig hÄmofili och dess behandling med humant anti-hÄmofiliglobulin. Nord. Med.56:1654, 1956

    Google Scholar 

  7. BlombÄck, M., Nilsson, I.M.: Treatment of hemophilia A with human antihemophilic globulin. Acta. Med. Scand.161:301, 1958

    Google Scholar 

  8. Pool, J.G., Robinson, J.: Observations on plasma banking and transfusion procedures for haemophilic patients using a quantitative assay for antihaemophilic globulin (AHG). Br. J. Haematol.5:24, 1959

    Google Scholar 

  9. Brinkhous, K.M., Shanbrom, E., Roberts, H.R., Webster, W.P., Fekete, L., Wagner, R.H.: A new high-potency glycineprecipitated antihemophilic factor (AHF) concentrate. JAMA205:613, 1968

    Google Scholar 

  10. Soulier, J.P., Blatrix, C., Steinbuch, M.: Fractions “coagulantes” contenant les facteurs de coagulation adsorbables par le phosphate tricalcique. Nouv. Presse Med.72:1223, 1964

    Google Scholar 

  11. Soulier, J.P., Ménaché, D., Steinbuch, M., Blatrix, Ch., Josso, F.: Preparation and clinical use of PPSB (factors II, VII, X and IX concentrate). Thromb. Diath. Haemorrh. Suppl.35:61, 1969

    Google Scholar 

  12. Josso, F., Steinbuch, M., Ménaché, D., Blatrix, C., Soulier, J.P.: Preparation of factor IX concentrates, with special reference to the PPSB fraction. In Hemophilia and New Hemorrhagic States, K.M. Brinkhous, editor. International Symposium, New York. Chapel Hill, University of North Carolina Press, 1970, pp. 14–21

    Google Scholar 

  13. Tullis, J.L., Melin, M., Jurigian, P.: Clinical use of human prothrombin complexes. N. Engl. J. Med.273:667, 1965

    Google Scholar 

  14. Britten, A.F.H., Salzman, E.W.: Surgery in congenital disorders of blood coagulation. Surg. Gynecol. Obstet.123:1333, 1966

    Google Scholar 

  15. Biggs, R.: Major surgery in haemophilic patients. In Treatment of Haemophilia and Other Coagulation Disorders, R. Biggs, R.G. MacFarlane, editors. Oxford, Blackwell Scientific Publications, 1966, pp. 166–194

    Google Scholar 

  16. Tarnay, Th.J.: Surgery in the Hemophiliac. Springfield, Ill., Charles C. Thomas, Publisher, 1968

    Google Scholar 

  17. Rudowski, W.J., Ziemski, J.M.: Extensive surgical procedures in patients with hemophilia A. Surg. Gynecol. Obstet.135:571, 1972

    Google Scholar 

  18. Post, M., Telfer, M.C.: Surgery in hemophilic patients. J. Bone Joint Surg.57A:1136, 1975

    Google Scholar 

  19. Björlin, G., Nilsson, I.M.: Tooth extractions in hemophiliacs after administration of a single dose of factor VIII or factor IX concentrate supplemented with AMCA. Oral Surg.36:482, 1973

    Google Scholar 

  20. Nilsson, I.M., BlombÄck, M., Ramgren, O.: Haemophilia in Sweden. I. Coagulation studies. Acta Med. Scand.170:665, 1961

    Google Scholar 

  21. Ramgren, O., Nilsson, I.M., BlombÄck, M.: Haemophilia in Sweden. IV. Hereditary investigations. Acta Med. Scand.171:759, 1962

    Google Scholar 

  22. Ramgren, O.: A clinical and medico-social study of haemophilia in Sweden. Acta Med. Scand. (Suppl.)379:111, 1962

    Google Scholar 

  23. Nilsson, I.M., Ramgren, O., BlombÄck, M., Ahlberg, å.: Addendum to the review of haemophilia in Sweden in 1962. Acta Orthop. Scand. (Suppl.)77:99, 1965

    Google Scholar 

  24. Niléhn, J.-E., Nilsson, I.M.: Haemophilia B in a girl. Thromb. Diath. Haemorrh.7:552, 1962

    Google Scholar 

  25. Nilsson, I.M., Ahlberg, å., Björlin, G.: Clinical experience with a Swedish factor IX concentrate. Acta Med. Scand.190:257, 1971

    Google Scholar 

  26. Nilsson, I.M., BlombÄck, M., Ahlberg, å.: Our experience in Sweden with prophylaxis on haemophilia. The haemophiliac and his world. Proceedings of the 5th Congress of the World Federation for Hemophilia, Montreal, 1968. Bibl. Haematol.34:111, 1970

    Google Scholar 

  27. Nilsson, I.M.: Haemorrhagic and Thrombotic Diseases. New York, John Wiley & Sons, 1974

    Google Scholar 

  28. Holmberg, L., Nilsson, I.M.: Immunologic studies in haemophilia A. Scand. J. Haematol.10:12, 1973

    Google Scholar 

  29. Nilsson, I.M., Hedner, U., Björlin, G.: Suppression of factor IX antibody in hemophilia B by factor IX and cyclophosphamide. Ann. Intern. Med.78:91, 1973

    Google Scholar 

  30. Nilsson, I.M., BlombÄck, M., Ramgren, O.: Haemophilia in Sweden. VI. Treatment of haemophilia A with the human antihaemophilic factor preparation (fraction I-0). Acta Med. Scand. (Suppl.)379:61, 1962

    Google Scholar 

  31. Abildgaard, C.F., Cornet, J.A., Fort, E., Schulman, I.: Thein vivo longevity of antihaemophilic factor (Factor VIII). Br. J. Haematol.10:225, 1964

    Google Scholar 

  32. Loeliger, E.A., Hensen, A., Mattern, M.J., Veltkamp, J.J., Bruning, P.F., Hemker, H.C.: Treatment of haemophilia B with purified factor IX (PPSB). Folia Med. Neerl.10:112, 1967

    Google Scholar 

  33. Biggs, R., Denson, K.W.E.: The fate of prothrombin and factors VIII, IX and X transfused to patients deficient in these factors. Br. J. Haematol.9:532, 1963

    Google Scholar 

  34. Nilsson, I.M., Hedner, U.: Immunosuppressive treatment in haemophiliacs with inhibitors to factor VIII and factor IX. Scand. J. Haematol. (in press)

  35. Duthie, R.B., Matthews, J.M., Rizza, Ch.R., Steel, W.M., Woods, C.G.: The Management of Musculo-skeletal Problems in the Haemophilias. Oxford, Blackwell Scientific Publications, 1972

    Google Scholar 

  36. Kasper, C.K.: To the editor: Postoperative thromboses in hemophilia B. N. Engl. J. Med.289:160, 1973

    Google Scholar 

  37. Blatt, P.M., Lundblad, R.L., Kingdon, H.S., McLean, G., Roberts, H.R.: Thrombogenic materials in prothrombin complex concentrates. Ann. Intern. Med.81:766, 1974

    Google Scholar 

  38. Kasper, C.K.: Thromboembolic complications. Thromb. Diath. Haemorrh.33:640, 1975

    Google Scholar 

  39. Hedner, U., Nilsson, I.M., Bergentz, S.-E.: Various prothrombin complex concentrates and their effect on coagulation and fibrinolysis in vivo. Thromb. Haemostas.35:386, 1976

    Google Scholar 

  40. Craske, J., Dilling, N., Stern, D.: An outbreak of hepatitis associated with intravenous injection of factor-VIII concentrate. Lancet2:221, 1975

    Google Scholar 

  41. Dane, D.S., Cameron, C.H.: Letter to the editor: Factor-VIII concentrate and hepatitis. Lancet2:328, 1975

    Google Scholar 

  42. Roberts, H.R., Blatt, P.M.: Post-transfusion hepatitis following the use of prothrombin complex concentrates. Thromb. Diath. Haemorrh.33:610, 1975

    Google Scholar 

  43. Björkman, S.E., Nilsson, I.M.: Demonstration of a fibrinolytic activator in red bone marrow. Acta Haematol. (Basel)26:273, 1961

    Google Scholar 

  44. MacFarlane, R.G., Biggs, R.: Haemophilia as a social problem. In Treatment of Haemophilia and Other Coagulation Disorders, R. Biggs, R.G. MacFarlane, editors. Oxford, Blackwell Scientific Publications, 1966, p. 328

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

International treatment and training centre of the World Federation of Hemophiliacs.

Supported by grants from the Swedish Medical Research Council (B76-19X-00087-12B), (B76-17X-00759-11B).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nilsson, I.M., Hedner, U., Ahlberg, å. et al. Surgery of hemophiliacs—20 years' experience. World J. Surg. 1, 55–66 (1977). https://doi.org/10.1007/BF01654733

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01654733

Keywords

Navigation